http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015107974-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45858ad8420337cf54fe6ca9ecc17337 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48f9110f7437313bbea23817223a463e |
| publicationDate | 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015107974-A |
| titleOfInvention | How to treat cancer |
| abstract | Disclosed is a method for treating glioblastoma or colorectal cancer with at least one hepatocyte growth factor (HGF) -Met inhibitor and at least one epidermal growth factor receptor (EGFR) inhibitor. A pharmaceutical composition comprising an HGF-Met inhibitor for administration with an EGFR inhibitor, wherein the HGF-Met inhibitor is antibody 2.12.1, and the EGFR inhibitor is panitumumab (EGFR antibody) A pharmaceutical composition suitable for administration of a therapeutically effective amount of an HGF-Met inhibitor simultaneously with an EGFR inhibitor, before an EGFR inhibitor, or after an EGFR inhibitor. [Selection figure] None |
| priorityDate | 2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1188.